Results 321 to 330 of about 4,166,507 (358)
Some of the next articles are maybe not open access.

Drug Discovery and Development

2016
International ...
Lézé, Samuel, Sidi-Boumedine, Farid
openaire   +1 more source

Drug development in neuropsychopharmacology

European Archives of Psychiatry and Clinical Neuroscience, 2008
Personalized medicine is still in its infancy concerning drug development in neuropsychopharmacology. Adequate biomarkers with clinical relevance to drug response and/or tolerability and safety largely remain to be identified. Possibly, this kind of personalized medicine will first gain clinical relevance in the dementias. The clinical relevance of the
openaire   +3 more sources

Antipsychotic Drug Development

2010
Schizophrenia typically manifests itself with a wide array of symptoms--positive, negative, cognitive, and affective--and may also involve neurodevelopmental and neurodegenerative aspects. Each of these symptom dimensions may be derived from pathology at one or more receptor types, localized in different regions of the brain.
Stephen M. Stahl, Dennis H. Kim
openaire   +3 more sources

The Development of Drugs

1990
The dictionary definition of drug is ‘A medical substance used alone or as an ingredient’. Although in common usage ‘drug’ tends to be associated with illegal stimulants, I will use it here to mean any substance administered with a view to producing physiological change (excluding the basic metabolic requirements of food, water and oxygen).
openaire   +2 more sources

“Precision” drug development?

Clinical Pharmacology & Therapeutics, 2015
The concept of precision medicine has entered broad public consciousness, spurred by a string of targeted drug approvals, highlighted by the availability of personal gene sequences, and accompanied by some remarkable claims about the future of medicine. It is likely that precision medicines will require precision drug development programs.
openaire   +3 more sources

Biosimulation in Drug Development

2007
PART I INTRODUCTION 1 Simulation in Clinical Drug Development 2 Modeling of Complex Biomedical Systems 3 Biosimulation of Drug Metabolism PART II SIMULATING CELLS AND TISSUES 4 Correlation Between In Vitro, In Situ, and In Vivo Models 5 Core-Box Modeling in the Biosimulation of Drug Action 6 The Glucose-Insulin Control System 7 Biological Rhythms in ...
Martin Bertau   +2 more
openaire   +3 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Drugs, conflict and development

International Journal of Drug Policy, 2021
Jonathan Goodhand   +4 more
openaire   +3 more sources

Drug development

Family & Community Health, 1982
openaire   +2 more sources

Home - About - Disclaimer - Privacy